Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Adverse events (ocular problems) · people with symptomatic vitreomacular adhesion

Ocriplasmin injection probably leads to higher any ocular adverse event compared with control (moderate certainty).

1 finding from 1 review

Ocriplasmin for symptomatic vitreomacular adhesion 2017 · Cochrane Headline outcomes only
RR 1.22 [1.09, 1.37]
Studies not reported
Moderate